The Swedish α1-antitrypsin screening study: Health status and lung and liver function at age 34

Annals of the American Thoracic Society

Volumn 12, Issue 6, 2015, Pages 807-812

  Tanash, Hanan A ^a   Nystedt Düzakin, Meltem ^a   Montero, Laura Cano ^a   Sveger, Tomas ^a   Piitulainen, Eeva ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Lung function; Neonatal screening; Respiratory symptoms; Smoking; 1 antitrypsin deficiency

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 1 ANTITRYPSIN; GAMMA GLUTAMYLTRANSFERASE; PROTEINASE INHIBITOR;

ADULT; ALCOHOL CONSUMPTION; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ALLERGIC URTICARIA; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CONTROLLED STUDY; DYSPNEA; ECZEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GROUPS BY AGE; HEALTH STATUS; HUMAN; INFANT; LIVER FUNCTION; LIVER FUNCTION TEST; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; POPULATION; PREVALENCE; QUALITY OF LIFE; REGISTER; SMOKING HABIT; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SWEDEN; WHEEZING; ALPHA 1-ANTITRYPSIN DEFICIENCY; HEALTH DISPARITY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SMOKING;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS DISPARITIES; HUMANS; INFANT, NEWBORN; LIVER FUNCTION TESTS; MALE; NEONATAL SCREENING; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SMOKING; SURVEYS AND QUESTIONNAIRES; SWEDEN;

EID: 84942241762     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201410-452OC     Document Type: Article

References (18)

1. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168: 818-900.
2. Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Survival in severe alpha-1-antitrypsin deficiency (PiZZ). Respir Res 2010;11:44.
3. Sveger T. Liver disease in a1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-1321.
4. Dahl M, Tybjærg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in a1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002;136:270-279.
5. O'Brien ML, Buist NR, Murphey WH. Neonatal screening for a1-antitrypsin deficiency. J Pediatr 1978;92:1006-1010.
6. Sveger T, Piitulainen E, Arborelius M Jr. Clinical features and lung function in 18-year-old adolescents with a1-antitrypsin deficiency. Acta Paediatr 1995;84:815-816.
7. Sveger T, Eriksson S. The liver in adolescents with a1-antitrypsin deficiency. Hepatology 1995;22:514-517.
8. Piitulainen E, Sveger T. Respiratory symptoms and lung function in young adults with severe a1-antitrypsin deficiency (PiZZ). Thorax 2002;57:705-708.
9. Bernspång E, Sveger T, Piitulainen E. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency. Respir Med 2007;101:1971-1976.
10. Piitulainen E, Montero LC, Nystedt-Düzakin M, Stoel BC, Sveger T, Wollmer P, Tanash HA, Diaz S. Lung function and CT densitometry in subjects with alpha-1-antitrypsin deficiency and healthy controls at 35 years of age. COPD (In press)
11. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31.
12. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158:1789-1795.
13. Quanjer PH. Standardized lung function testing: Official Statement of the European Respiratory Society. Eur Respir J 1993;6(Suppl 16): 1-100.
14. Turner S. Exhaled nitric oxide in the diagnosis and management of asthma. Curr Opin Allergy Clin Immunol 2008;8:70-76.
15. Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, Fallat RJ, Stoller JK, Crystal RG, Turino GM. Asthma features in severe a1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 2003;123:765-771.
16. Eden E, Strange C, Holladay B, Xie L. Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med 2006;100:1384-1391.
17. Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, Bradding P, Wardlaw AJ, Pavord ID. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007;62:1043-1049.
18. Doll H, Miravitlles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics 2005;23:345-363.